85 related articles for article (PubMed ID: 8855799)
21. Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene.
Koh CS; Ku JL; Park SY; Kim KH; Choi JS; Kim IJ; Park JH; Oh SK; Chung JK; Lee JH; Kim WH; Kim CW; Cho BY; Park JG
Mol Cell Endocrinol; 2007 Jan; 264(1-2):118-27. PubMed ID: 17134824
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin-induced genes as potential markers for thyroid cancer.
Lapouge G; Millon R; Muller D; Abecassis J; Eber M; Bergerat JP; Klein-Soyer C
Cell Mol Life Sci; 2005 Jan; 62(1):53-64. PubMed ID: 15619007
[TBL] [Abstract][Full Text] [Related]
23. The secretion of cytokines and granulocyte colony stimulating factor by anaplastic and poorly differentiated thyroid carcinoma cell lines.
Asakawa H; Kobayashi T
Anticancer Res; 1999; 19(1B):761-4. PubMed ID: 10216489
[TBL] [Abstract][Full Text] [Related]
24. Glycerol enhances CDDP-induced growth inhibition of thyroid anaplastic carcinoma tumor carrying mutated p53 gene.
Yuki K; Takahashi A; Ota I; Ohnishi K; Yasumoto J; Kanata H; Yane K; Hosoi H; Ohnishi T
Oncol Rep; 2004 Apr; 11(4):821-4. PubMed ID: 15010879
[TBL] [Abstract][Full Text] [Related]
25. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.
Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R
Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266
[TBL] [Abstract][Full Text] [Related]
26. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
Donghi R; Longoni A; Pilotti S; Michieli P; Della Porta G; Pierotti MA
J Clin Invest; 1993 Apr; 91(4):1753-60. PubMed ID: 8473515
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid.
Yamashita T; Watanabe M; Onodera M; Shimaoka K; Ito K; Fujimoto Y; Itoyama S; Sugawara I
Cancer Detect Prev; 1994; 18(5):407-13. PubMed ID: 7812988
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
[TBL] [Abstract][Full Text] [Related]
29. Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo.
Stenner F; Liewen H; Zweifel M; Weber A; Tchinda J; Bode B; Samaras P; Bauer S; Knuth A; Renner C
Cancer Sci; 2008 Sep; 99(9):1847-52. PubMed ID: 18616678
[TBL] [Abstract][Full Text] [Related]
30. BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.
Gauchotte G; Philippe C; Lacomme S; LĂ©otard B; Wissler MP; Allou L; Toussaint B; Klein M; Vignaud JM; Bressenot A
Pathology; 2011 Aug; 43(5):447-52. PubMed ID: 21716161
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.
Mitsiades CS; Kotoula V; Poulaki V; Sozopoulos E; Negri J; Charalambous E; Fanourakis G; Voutsinas G; Tseleni-Balafouta S; Mitsiades N
J Clin Endocrinol Metab; 2006 Sep; 91(9):3662-6. PubMed ID: 16822827
[TBL] [Abstract][Full Text] [Related]
32. p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer.
Bergqvist M; Brattström D; Gullbo J; Hesselius P; Brodin O; Wagenius G
Anticancer Res; 2003; 23(2B):1207-12. PubMed ID: 12820372
[TBL] [Abstract][Full Text] [Related]
33. [Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by ciclosporin A and verapamil].
Massart C; Gibassier J; Lucas C; Pourquier P; Robert J
Bull Cancer; 1996 Jan; 83(1):39-45. PubMed ID: 8672855
[TBL] [Abstract][Full Text] [Related]
34. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
Pinto AE; Silva G; Banito A; Leite V; Soares J
Oncol Rep; 2008 Oct; 20(4):913-9. PubMed ID: 18813835
[TBL] [Abstract][Full Text] [Related]
35. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
[TBL] [Abstract][Full Text] [Related]
36. [Thyroid carcinoma].
Namba H; Izumi M
Gan To Kagaku Ryoho; 1991 Jan; 18(1):22-9. PubMed ID: 1987898
[TBL] [Abstract][Full Text] [Related]
37. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.
Chen G; Xu S; Renko K; Derwahl M
J Clin Endocrinol Metab; 2012 Apr; 97(4):E510-20. PubMed ID: 22278418
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
[TBL] [Abstract][Full Text] [Related]
39. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
40. Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells.
Chang FL; Lai MD
J Urol; 2001 Jul; 166(1):304-10. PubMed ID: 11435891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]